BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31912675)

  • 1. Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma.
    Iijima M; Okonogi N; Nakajima NI; Morokoshi Y; Kanda H; Yamada T; Kobayashi Y; Banno K; Wakatsuki M; Yamada S; Kamada T; Aoki D; Hasegawa S
    J Gynecol Oncol; 2020 Mar; 31(2):e19. PubMed ID: 31912675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between radiotherapy-induced alteration of programmed death ligand 1 and survival in patients with uterine cervical cancer undergoing preoperative radiotherapy.
    Tsuchiya T; Someya M; Takada Y; Hasegawa T; Kitagawa M; Fukushima Y; Gocho T; Hori M; Nakata K; Hirohashi Y; Torigoe T; Saito T; Sakata KI
    Strahlenther Onkol; 2020 Aug; 196(8):725-735. PubMed ID: 31953603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
    Kobayashi N; Oike T; Ando K; Murata K; Tamaki T; Noda SE; Kogure K; Nobusawa S; Oyama T; Ohno T
    J Med Case Rep; 2024 May; 18(1):228. PubMed ID: 38720351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy.
    Darwis NDM; Nachankar A; Sasaki Y; Matsui T; Noda SE; Murata K; Tamaki T; Ando K; Okonogi N; Shiba S; Irie D; Kaminuma T; Kumazawa T; Anakura M; Yamashita S; Hirakawa T; Kakoti S; Hirota Y; Tokino T; Iwase A; Ohno T; Shibata A; Oike T; Nakano T
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
    J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
    Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas.
    Reddy OL; Shintaku PI; Moatamed NA
    Diagn Pathol; 2017 Jun; 12(1):45. PubMed ID: 28623908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
    Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
    Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High linear energy transfer carbon-ion irradiation upregulates PD-L1 expression more significantly than X-rays in human osteosarcoma U2OS cells.
    Permata TBM; Sato H; Gu W; Kakoti S; Uchihara Y; Yoshimatsu Y; Sato I; Kato R; Yamauchi M; Suzuki K; Oike T; Tsushima Y; Gondhowiardjo S; Ohno T; Yasuhara T; Shibata A
    J Radiat Res; 2021 Sep; 62(5):773-781. PubMed ID: 34196706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of radiotherapy-induced alteration of CD8
    Mori Y; Sato H; Kumazawa T; Permata TBM; Yoshimoto Y; Murata K; Noda SE; Kaminuma T; Ando K; Oike T; Okonogi N; Okada K; Kakoti S; Suzuki K; Ikota H; Yokoo H; Nakano T; Ohno T; Shibata A
    Oncol Lett; 2021 Jun; 21(6):446. PubMed ID: 33868484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix.
    Kato S; Ohno T; Tsujii H; Nakano T; Mizoe JE; Kamada T; Miyamoto T; Tsuji H; Kato H; Yamada S; Kandatsu S; Yoshikawa K; Ezawa H; Suzuki M;
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):388-97. PubMed ID: 16626894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer.
    D'Alessandris N; Palaia I; Pernazza A; Tomao F; Di Pinto A; Musacchio L; Leopizzi M; Di Maio V; Pecorella I; Benedetti Panici P; Della Rocca C
    Virchows Arch; 2021 Mar; 478(3):517-525. PubMed ID: 32915266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Outcomes of Carbon-ion Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Uterine Cervix.
    Okonogi N; Wakatsuki M; Kato S; Shiba S; Kobayashi D; Kiyohara H; Karasawa K; Ohno T; Nakano T; Kamada T; Shozu M;
    Anticancer Res; 2018 Jan; 38(1):457-463. PubMed ID: 29277809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients.
    Omenai SA; Ajani MA; Okolo CA
    PLoS One; 2022; 17(2):e0263615. PubMed ID: 35139126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.
    Okonogi N; Usui H; Murata K; Hori M; Kurokawa T; Fujiwara T; Fujii Y; Hanawa M; Kawasaki Y; Hattori Y; Suzuki K; Tsuyuki K; Wakatsuki M; Hasegawa S; Yamada S; Hanaoka H; Shozu M; Tsuji H
    BMJ Open; 2022 Mar; 12(3):e056424. PubMed ID: 35236732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.
    Lee VH; Lo AW; Leung CY; Shek WH; Kwong DL; Lam KO; Tong CC; Sze CK; Leung TW
    PLoS One; 2016; 11(6):e0157969. PubMed ID: 27341634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of programmed death-ligand 1 after neo-adjuvant chemotherapy in patients with lung squamous cell carcinoma.
    Song Z; Yu X; Zhang Y
    Lung Cancer; 2016 Sep; 99():166-71. PubMed ID: 27565935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of carbon ion radiotherapy with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma in a phase 1/2 clinical trial (Protocol 1001).
    Okonogi N; Wakatsuki M; Kato S; Karasawa K; Kiyohara H; Shiba S; Kobayashi D; Nakano T; Kamada T; Shozu M;
    Cancer Med; 2018 Feb; 7(2):351-359. PubMed ID: 29341491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.